中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

23 records (took 0.03 seconds)

    CURRENT DENSITY DETECTION AND CONTROL SYSTEM AND METHOD FOR AN ELECTROKINETIC DELIVERY OF MEDICAMENTS
    1.
    发明申请
    CURRENT DENSITY DETECTION AND CONTROL SYSTEM AND METHOD FOR AN ELECTROKINETIC DELIVERY OF MEDICAMENTS 审中-公开
    电流密度检测与控制系统及其药物输送方法

    公开(公告)号：US20080262581A1

    公开(公告)日：2008-10-23

    申请号：US12104515

    申请日：2008-04-17

    Applicant: Michael S. Barsness ,  Edward J. Doherty

    Inventor： Michael S. Barsness ,  Edward J. Doherty

    IPC: A61N1/00

    CPC classification number: A61N1/044 ,  A61N1/0448 ,  A61N1/08 ,  A61N1/325

    Abstract: An apparatus to monitor current density in the application of medicament to a treatment site of a mammalian user of a electrokinetic device including: an applicator cartridge including an active electrode, a matrix carrying a medicament or a medicament and an electrically conductive carrier; a device including an electrical power source connectable to the active electrode, a counter electrode, and an electronic circuit configured to control the application of electrical current through the active electrode to establish a conductive path extending from the power source, through the active electrode, matrix, the treatment site, the user and the counter electrode electrically connected to the power source, and an array of contacts monitoring current density flowing through the matrix and to the treatment site, wherein the array of sensors are arranged monitor the current density at various locations of the matrix and a contact area between the matrix and skin above the treatment site.

    Abstract translation: 一种用于监测将药物施用于电动装置的哺乳动物使用者的治疗部位的电流密度的装置，包括：施用器盒，其包括有源电极，承载药物或药物的基质和导电载体; 包括可连接到有源电极的电源的设备，对电极和被配置为控制通过有源电极的电流的施加以建立从电源延伸通过有源电极矩阵的导电路径的电子电路 电连接到电源的处理部位，用户和对电极以及监测流经矩阵和处理部位的电流密度的触点阵列，其中布置的传感器阵列监视各个位置处的电流密度 的基质和基质和皮肤在治疗部位之上的接触面积。

    Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation
    3.
    发明授权
    Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation 失效
    通过基因转化控制生物人工器官中包封前后细胞的增殖

    公开(公告)号：US5843431A

    公开(公告)日：1998-12-01

    申请号：US432698

    申请日：1995-05-09

    Applicant: Malcolm Schinstine ,  Molly S. Shoichet ,  Frank T. Gentile ,  Joseph P. Hammang ,  Laura M. Holland ,  Brian M. Cain ,  Edward J. Doherty ,  Shelley R. Winn ,  Patrick Aebischer

    Inventor： Malcolm Schinstine ,  Molly S. Shoichet ,  Frank T. Gentile ,  Joseph P. Hammang ,  Laura M. Holland ,  Brian M. Cain ,  Edward J. Doherty ,  Shelley R. Winn ,  Patrick Aebischer

    IPC: A01K67/027 ,  A61K48/00 ,  A61L27/00 ,  A61L27/18 ,  A61L27/22 ,  A61L27/38 ,  C07K14/82 ,  C12N5/00 ,  C12N5/10 ,  C12N15/09 ,  C12N15/12 ,  C12N11/00 ,  C12N11/10

    CPC classification number: A61L27/3839 ,  A61L27/18 ,  A61L27/227 ,  C07K14/82 ,  C12N5/0012 ,  C12N5/0068 ,  A61K48/00 ,  C12N2510/00 ,  C12N2510/04 ,  C12N2533/30 ,  C12N2533/54 ,  C12N2533/74

    Abstract: Methods and compositions are provided for controlling cell distribution within an implantable bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibiting compound; exposing the cells to irradiation, and (3) modifying a growth surface of the bioartificial organ with extracellular matrix molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination. Cells can be transformed with a proliferation-promoting gene such as the oncogene, SV40, linked to a regulatable promoter such as the Mx1 promoter, the promotor is activated in vitro to express the gene to result in cell proliferation, and the promotor is inactivated before or after insertion of the cells in the bioartificial organ to inhibit expression of the gene to reduce or stop cell proliferation in vivo. The promoter can be reactivated in vivo to again express the gene to result in further cell proliferation. The gene may be a proliferation-suppressing gene such as p53 gene or RB gene, or a differentiation-inducing gene such as high mobility group chromosomal protein 14. Inhibiting gene expression in vitro causes cell proliferation, and inducing gene expression reduces or stops cell proliferation in vivo.

    Abstract translation: 提供了用于通过将细胞暴露于抑制细胞增殖，促进细胞分化或影响细胞附着于生物人造器官内的生长表面的处理来控制可植入的生物人造器官内的细胞分布的方法和组合物。 这样的处理包括（1）遗传操纵细胞，（2）将细胞暴露于增殖抑制化合物或分化诱导化合物，或除去细胞暴露于增殖刺激化合物或分化抑制化合物; 将细胞暴露于照射下，和（3）用细胞外基质分子，影响细胞增殖或粘附的分子，或惰性支架或其组合修饰生物人造器官的生长表面。 这些处理可以组合使用。 可以用增殖促进基因转化细胞，例如与可调节启动子如Mx1启动子连接的癌基因SV40，启动子在体外被激活以表达基因以导致细胞增殖，并且启动子在 或在细胞插入生物人造器官中以抑制基因表达以减少或停止体内细胞增殖。 启动子可以在体内再活化以再次表达基因以导致进一步的细胞增殖。 该基因可以是增殖抑制基因如p53基因或RB基因，或分化诱导基因如高迁移率组染色体蛋白14.体外抑制基因表达引起细胞增殖，诱导基因表达降低或停止细胞增殖 体内。

    Method and apparatus for sealing implantable, membrane encapsulation
    4.
    发明授权
    Method and apparatus for sealing implantable, membrane encapsulation 失效
    用于密封植入式膜封装的方法和装置

    公开(公告)号：US5653687A

    公开(公告)日：1997-08-05

    申请号：US490112

    申请日：1995-06-06

    Applicant: John F. Mills ,  Edward J. Doherty ,  Tyrone F. Hazlett ,  Keith E. Dionne ,  Nicholas F. Warner ,  Brian M. Cain ,  David H. Rein

    Inventor： John F. Mills ,  Edward J. Doherty ,  Tyrone F. Hazlett ,  Keith E. Dionne ,  Nicholas F. Warner ,  Brian M. Cain ,  David H. Rein

    IPC: A61M31/00 ,  A61K9/00

    CPC classification number: A61K9/0024

    Abstract: A sealed, implantable, encapsulation device (20) for diffusing a biologically active product or function to an individual which includes a substantially non-porous fitting (32) including an inner surface (33) defining an access port (34). A permselective, porous, membrane (21), having an interior surface (22), cooperates with the fitting inner surface (33) to form a storage cavity (23) therebetween. The membrane interior surface (22) is in substantially cell-tight dry sealing engagement with fitting (32) to seal cavity (23). Living cells (24) are disposed in the cavity (23) which are capable of secreting the biologically active product to an individual. The membrane (21) is of a material capable of permitting the passage of substances between the individual and cells required to provide the biological product or function. A plug member (35) is positioned in the access port (34) and seated in cell-tight sealing engagement with the fitting inner surface (33). A method for sealing the implantable encapsulation device (20) is also provided.

    Abstract translation: 一种用于将生物活性产品或功能扩散到个体的密封的可植入的包封装置（20），其包括基本上无孔的配件（32），其包括限定出入口（34）的内表面（33）。 具有内表面（22）的选择性选择性多孔的膜（21）与配合内表面（33）配合以在其间形成储存腔（23）。 膜内表面（22）与配件（32）基本上牢固地密封地密封接合以密封空腔（23）。 活细胞（24）设置在空腔（23）中，其能够将生物活性产物分泌给个体。 膜（21）是能够允许个体与提供生物产物或功能所需的细胞之间的物质通过的材料。 插头构件（35）定位在进入口（34）中并且与配件内表面（33）牢固地密封接合。 还提供了一种用于密封可植入封装装置（20）的方法。

    Method and apparatus for sealing implantable, membrane encapsulation devices
    7.
    发明授权
    Method and apparatus for sealing implantable, membrane encapsulation devices 失效
    用于密封植入式膜封装装置的方法和装置

    公开(公告)号：US5738673A

    公开(公告)日：1998-04-14

    申请号：US476498

    申请日：1995-06-07

    Applicant: John F. Mills ,  Edward J. Doherty ,  Tyrone F. Hazlett ,  Keith E. Dionne ,  Nicholas F. Warner ,  Brian M. Cain ,  David H. Rein

    Inventor： John F. Mills ,  Edward J. Doherty ,  Tyrone F. Hazlett ,  Keith E. Dionne ,  Nicholas F. Warner ,  Brian M. Cain ,  David H. Rein

    IPC: A61M31/00 ,  A61K9/00 ,  A61K9/22

    CPC classification number: A61K9/0024

    Abstract: A sealed, implantable, encapsulation device (20) for diffusing a biologically active product or function to an individual which includes a substantially non-porous fitting (32) including an inner surface (33) defining an access port (34). A permselective, porous, membrane (21), having an interior surface (22), cooperates with the fitting inner surface (33) to form a storage cavity (23) therebetween. The membrane interior surface (22) is in substantially cell-tight dry sealing engagement with fitting (32) to seal cavity (23). Living cells (24) are disposed in the cavity (23) which are capable of secreting the biologically active product to an individual. The membrane (21) is of a material capable of permitting the passage of substances between the individual and cells required to provide the biological product or function. A plug member (35) is positioned in the access port (34) and seated in cell-tight sealing engagement with the fitting inner surface (33). A method for sealing the implantable encapsulation device (20) is also provided.

    Abstract translation: 一种用于将生物活性产品或功能扩散到个体的密封的可植入的包封装置（20），其包括基本上无孔的配件（32），其包括限定出入口（34）的内表面（33）。 具有内表面（22）的选择性选择性多孔的膜（21）与配合内表面（33）配合以在其间形成储存腔（23）。 膜内表面（22）与配件（32）基本上牢固地密封地密封接合以密封空腔（23）。 活细胞（24）设置在空腔（23）中，其能够将生物活性产物分泌给个体。 膜（21）是能够允许个体与提供生物产物或功能所需的细胞之间的物质通过的材料。 插头构件（35）定位在进入口（34）中并且与配件内表面（33）牢固地密封接合。 还提供了一种用于密封可植入封装装置（20）的方法。

    Method and apparatus for sealing implantable membrane encapsulation devices
    10.
    发明授权
    Method and apparatus for sealing implantable membrane encapsulation devices 失效
    用于密封可植入膜包封装置的方法和装置

    公开(公告)号：US6123700A

    公开(公告)日：2000-09-26

    申请号：US016223

    申请日：1998-01-30

    Applicant: John F. Mills ,  Edward J. Doherty ,  Tyrone F. Hazlett ,  Keith E. Dionne ,  Nicholas F. Warner ,  Brian M. Cain ,  David H. Rein

    Inventor： John F. Mills ,  Edward J. Doherty ,  Tyrone F. Hazlett ,  Keith E. Dionne ,  Nicholas F. Warner ,  Brian M. Cain ,  David H. Rein

    IPC: A61M31/00 ,  A61K9/00 ,  A61K9/22

    CPC classification number: A61K9/0024

    Abstract: A sealed, implantable, encapsulation device (20) for diffusing a biologically active product or function to an individual which includes a substantially non-porous fitting (32) including an inner surface (33) defining an access port (34). A permselective, porous, membrane (21), having an interior surface (22), cooperates with the fitting inner surface (33) to form a storage cavity (23) therebetween. The membrane interior surface (22) is in substantially cell-tight dry sealing engagement with fitting (32) to seal cavity (23). Living cells (24) are disposed in the cavity (23) which are capable of secreting the biologically active product to an individual. The membrane (21) is of a material capable of permitting the passage of substances between the individual and cells required to provide the biological product or function. A plug member (35) is positioned in the access port (34) and seated in cell-tight sealing engagement with the fitting inner surface (33). A method for sealing the implantable encapsulation device (20) is also provided.

    Abstract translation: 一种用于将生物活性产品或功能扩散到个体的密封的可植入的包封装置（20），其包括基本上无孔的配件（32），其包括限定出入口（34）的内表面（33）。 具有内表面（22）的选择性选择性多孔的膜（21）与配合内表面（33）配合以在其间形成储存腔（23）。 膜内表面（22）与配件（32）基本上牢固地密封地密封接合以密封空腔（23）。 活细胞（24）设置在空腔（23）中，其能够将生物活性产物分泌给个体。 膜（21）是能够允许个体与提供生物产物或功能所需的细胞之间的物质通过的材料。 插头构件（35）定位在进入口（34）中并且与配件内表面（33）牢固地密封接合。 还提供了一种用于密封可植入封装装置（20）的方法。

Patent Agency Ranking